1. Home
  2. PRQR vs ARAI Comparison

PRQR vs ARAI Comparison

Compare PRQR & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • ARAI
  • Stock Information
  • Founded
  • PRQR 2012
  • ARAI 2020
  • Country
  • PRQR Netherlands
  • ARAI United States
  • Employees
  • PRQR N/A
  • ARAI N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • ARAI Diversified Commercial Services
  • Sector
  • PRQR Health Care
  • ARAI Finance
  • Exchange
  • PRQR Nasdaq
  • ARAI Nasdaq
  • Market Cap
  • PRQR 224.4M
  • ARAI 190.6M
  • IPO Year
  • PRQR 2014
  • ARAI N/A
  • Fundamental
  • Price
  • PRQR $2.80
  • ARAI $4.86
  • Analyst Decision
  • PRQR Strong Buy
  • ARAI
  • Analyst Count
  • PRQR 8
  • ARAI 0
  • Target Price
  • PRQR $8.88
  • ARAI N/A
  • AVG Volume (30 Days)
  • PRQR 649.8K
  • ARAI 605.2K
  • Earning Date
  • PRQR 11-07-2025
  • ARAI 08-14-2025
  • Dividend Yield
  • PRQR N/A
  • ARAI N/A
  • EPS Growth
  • PRQR N/A
  • ARAI N/A
  • EPS
  • PRQR N/A
  • ARAI N/A
  • Revenue
  • PRQR $20,129,184.00
  • ARAI $90,725.00
  • Revenue This Year
  • PRQR N/A
  • ARAI N/A
  • Revenue Next Year
  • PRQR N/A
  • ARAI N/A
  • P/E Ratio
  • PRQR N/A
  • ARAI N/A
  • Revenue Growth
  • PRQR 8.65
  • ARAI N/A
  • 52 Week Low
  • PRQR $1.07
  • ARAI $3.03
  • 52 Week High
  • PRQR $4.21
  • ARAI $40.00
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 60.30
  • ARAI N/A
  • Support Level
  • PRQR $2.71
  • ARAI N/A
  • Resistance Level
  • PRQR $3.00
  • ARAI N/A
  • Average True Range (ATR)
  • PRQR 0.24
  • ARAI 0.00
  • MACD
  • PRQR 0.01
  • ARAI 0.00
  • Stochastic Oscillator
  • PRQR 71.11
  • ARAI 0.00

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About ARAI Arrive AI Inc. Common Stock

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: